Mounting Pressure, Lacking Clarity

Mounting Pressure, Lacking Clarity

Obesity has grown to a full-scale epidemic over the last 40 years. The latest innovation in weight management is the GLP-1 drug class. Originally developed for diabetes, these medications have become synonymous with weight loss. Unfortunately, they are also synonymous with high cost.

As the pressure to make a coverage decision mounts for those responsible for pharmacy benefits, leaders need clear answers that cut through the opinions and noise. Watch the pharmacist-led webcast at your convenience.

View the Recording
Session Overview

Session Overview

Our pharmacists will discuss GLP-1s, analyze potential pharmacy benefit strategies, and evaluate potential member and plan impact.

Highlights:

  • Examine the research on clinical impacts, discuss emerging concerns and explore the pharmaceutical pipeline
  • Walk away with a better understanding of the cost to cover the drug for weight loss and a recommended course of action.

Watch the webcast on demand at your convenience.

View the Recording
  • Panelists

    Jim Harenberg, CPBS
    Chief Operating Officer

    Read Bio

  • Amy Ball, PharmD
    President

    Read Bio

  • Megan Dorrell, PharmD, BCACP
    Vice President of Clinical Strategy

    Read Bio
  • Shravan Patel, PharmD
    Managed Care Pharmacy Resident

    Read Bio

Insights